Ocado Group plc (OCDO) is a leading grocery stores business based in the UK. It opened the day at 2857p after a previous close of 2893p. During the day the price has varied from a low of 2837p to a high of 2904p. The latest price was 2895p (25 minute delay). Ocado is listed on the London Stock Exchange (LSE) and employs 15,152 staff. All prices are listed in pence sterling.
Since the stock market crash in March caused by coronavirus, Ocado's share price has had significant positive movement.
Its last market close was 2461p, which is 53.86% up on its pre-crash value of 1135.5p and 147.58% up on the lowest point reached during the March crash when the shares fell as low as 994.0121p.
If you had bought £1,000 worth of Ocado shares at the start of February 2020, those shares would have been worth £1,015.69 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £1,975.20.
|52-week range||994.0121p - 2914p|
|50-day moving average||2558.1143p|
|200-day moving average||2127.5923p|
|Wall St. target price||985.69p|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||-24.7p|
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 week (2020-10-21)||19.38%|
|1 month (2020-09-28)||1.40%|
|3 months (2020-07-28)||39.72%|
|6 months (2020-04-28)||75.30%|
|1 year (2019-10-28)||114.37%|
|2 years (2018-10-26)||270.02%|
|3 years (2017-10-27)||929.15%|
|5 years (2015-10-28)||704.39%|
Valuing Ocado stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ocado's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Ocado's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £60.2 million.
The EBITDA is a measure of a Ocado's overall financial performance and is widely used to measure a its profitability.
To put Ocado's EBITDA into context you can compare it against that of similar companies.
|Revenue TTM||£2 billion|
|Operating margin TTM||0.12%|
|Gross profit TTM||£597.3 million|
|Return on assets TTM||0.07%|
|Return on equity TTM||-14.06%|
|Market capitalisation||£18.4 billion|
TTM: trailing 12 months
We're not expecting Ocado to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
You may also wish to consider:
Over the last 12 months, Ocado's shares have ranged in value from as little as 994.0121p up to 2914p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Ocado's is 1.0117. This would suggest that Ocado's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
To put Ocado's beta into context you can compare it against those of similar companies.
Ocado Group plc operates as an online grocery retailer in the United Kingdom and internationally. The company operates through three segments: Ocado Retail, UK Solutions & Logistics, and International Solutions. It sells general merchandise products on its Ocado.com; and operates Fetch, a pet store, as well as Sizzle, a kitchen and dining store. The company also provides online retail solutions; and customer fulfillment centers (CFCs) and logistics services for Ocado Retail and Morrisons. Ocado Group plc has a strategic partnership with The Kroger Co. to construct three new CFCs in the Great Lakes, Pacific Northwest, and West regions. The company was founded in 2000 and is headquartered in Hatfield, the United Kingdom.
Everything we know about the Virpax Pharmaceuticals IPO, plus information on how to buy it.
Everything we know about the Vivos Therapeutics IPO, plus information on how to buy it.
Everything we know about the Kiromic Biopharma IPO, plus information on how to buy it.
Everything we know about the Codiak BioSciences IPO, plus information on how to buy it.
Everything we know about the Triller IPO, plus information on how to buy it.
Everything we know about the Eastern Bank IPO, plus information on how to buy it.
Everything we know about the Wish IPO, plus information on how to buy it.
Everything we know about the MINISO Group Holding Limited IPO, plus information on how to buy it.
Everything we know about the Playboy IPO, plus information on how to buy it.
Everything we know about the iHuman IPO, plus information on how to buy it.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.